Zepbound Prescription in Fort Worth at DFWPMA

Looking for Zepbound prescriptions in Fort Worth, Texas? Zepbound (tirzepatide) is a prescription weight-management medication that requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can cause serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology, internal medicine, and family medicine physicians conduct comprehensive evaluations of weight-related health conditions, metabolic health, medical history, and treatment risks.

DFWPMA offers Zepbound prescription evaluations in Fort Worth and can prescribe Zepbound to eligible patients when medically appropriate. Zepbound is FDA-approved for chronic weight management in qualifying adults and for moderate-to-severe obstructive sleep apnea in adults with obesity.

Book an appointment online or call (903) 957-0082 to contact our Fort Worth location.

Address: 📍 1220 W. Presidio St., Fort Worth, TX 76102
Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for Zepbound Prescriptions in Fort Worth?

DFW Physicians Medical Associates provides Zepbound prescription evaluations in Fort Worth through physicians experienced in endocrinology, metabolic health, chronic disease management, and comprehensive medical care. Our multispecialty approach supports individualized weight-management evaluations and ongoing medical supervision.

Patients seeking Zepbound prescriptions at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology, internal medicine, and family medicine physicians experienced in metabolic health, chronic disease management, and medication evaluations.
  • Comprehensive Eligibility Assessment: Evaluation of body mass index (BMI), weight-related medical conditions, treatment history, and potential contraindications before prescribing Zepbound.
  • Weight and Metabolic Health Evaluation: Assessment of obesity, blood glucose, blood pressure, cholesterol, and other metabolic indicators when clinically appropriate.
  • Individualized Prescription Decisions: Treatment recommendations based on medical eligibility, weight-management goals, clinical risks, and overall health.
  • Medication Safety Screening: Review of contraindications and precautions involving thyroid cancer history, pancreatitis, gastrointestinal disorders, gallbladder disease, and other relevant conditions.
  • Dosage Management and Monitoring: Gradual dose adjustments, medication tolerance assessments, and monitoring for potential side effects.
  • Long-Term Weight Management: Ongoing evaluation of weight changes, metabolic health, treatment effectiveness, and sustainable lifestyle modifications.
  • Coordinated Multispecialty Care: Access to additional medical and behavioral health services when patients require comprehensive support for weight-related health concerns.

Zepbound is not appropriate for every patient seeking weight loss. Prescribing decisions require evaluating obesity-related health risks, potential adverse effects, medication contraindications, and alternative treatment options.

At DFWPMA, comprehensive medical evaluation and individualized treatment planning are central to determining whether Zepbound is an appropriate weight-management medication.

Schedule an appointment with DFWPMA Fort Worth to discuss Zepbound prescription eligibility and your weight-management options.

Meet Our Zepbound Prescription Providers in Fort Worth

DFWPMA Fort Worth offers Zepbound prescription evaluations through physicians whose clinical expertise includes endocrinology, internal medicine, family medicine, metabolic disorders, and chronic disease management. These providers can assess medical eligibility and determine whether Zepbound is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes weight management, metabolic disorders, type 1 and type 2 diabetes, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in weight management and metabolic health is particularly relevant for patients seeking Zepbound prescription evaluations, including individuals with obesity and related metabolic conditions.

Soheila Hesami, MD – Internal Medicine

Dr. Soheila Hesami is a board-certified internal medicine physician with more than 20 years of experience providing comprehensive healthcare for adults and older adults.

Her clinical expertise includes diabetes care, hypertension, high cholesterol, chronic disease management, medication management, preventive medicine, and comprehensive health evaluations.

Dr. Hesami’s experience managing metabolic risk factors and chronic medical conditions supports Zepbound prescription evaluations, including assessment of obesity-related health concerns, medication safety, and individualized treatment planning.

Anisha Zaman, MD – Family Medicine

Dr. Anisha Zaman is a family medicine physician providing comprehensive outpatient care, preventive medicine, and chronic disease management in Fort Worth.

Her clinical background includes diabetes management, hypertension treatment, patient education, preventive healthcare, and lifestyle-focused medical care. She completed her family medicine residency at the University of Arkansas for Medical Sciences.

Dr. Zaman’s experience in chronic disease management and preventive healthcare supports medical evaluations for patients considering Zepbound, including assessment of weight-related conditions, treatment eligibility, and long-term health goals.

Michael Huang, MD – Family Medicine

Dr. Michael Huang is a board-certified family medicine physician with more than 13 years of clinical experience providing preventive healthcare, chronic disease management, and comprehensive medical care.

His expertise includes diabetes management, hypertension, preventive medicine, treatment of acute illnesses, and long-term management of chronic health conditions. Dr. Huang provides care in English and Spanish.

His experience managing diabetes and related metabolic conditions is relevant to Zepbound prescription evaluations, medication monitoring, and comprehensive weight-related health assessments.

Book an appointment online to inquire about Zepbound prescription evaluations with DFWPMA’s medical providers in Fort Worth.

What Can a Zepbound Prescription in Fort Worth Help With?

Zepbound (tirzepatide) is a weekly GIP and GLP-1 receptor agonist approved for chronic weight management in eligible adults and moderate-to-severe obstructive sleep apnea in adults with obesity. It helps regulate appetite, reduce food intake, and support weight loss alongside dietary changes and physical activity.

At DFWPMA Fort Worth, Zepbound prescription evaluations address:

  • Obesity Treatment: Supporting chronic weight management in adults with a BMI of 30 or higher.
  • Overweight With Related Health Conditions: Treating eligible adults with a BMI of 27 or higher and a weight-related medical condition.
  • Chronic Weight Management: Supporting clinically meaningful weight loss and long-term weight maintenance.
  • Appetite Regulation: Reducing appetite and food intake through GIP and GLP-1 receptor activation.
  • Obstructive Sleep Apnea: Treating moderate-to-severe obstructive sleep apnea in adults with obesity.
  • Weight-Related Metabolic Conditions: Supporting weight management in eligible patients with hypertension, high cholesterol, or type 2 diabetes.
  • Weight Management After Previous Treatment: Evaluating Zepbound when lifestyle interventions or previous weight-management treatments have produced insufficient results.

Zepbound activates GIP and GLP-1 receptors involved in appetite regulation and metabolic function. Its effects on hunger and food intake can produce substantial weight loss in eligible patients.

The American College of Physicians recommends considering tirzepatide among first-line medication options for eligible adults with obesity or overweight and associated medical conditions, alongside lifestyle modifications.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Zepbound is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important risks include pancreatitis, gastrointestinal complications, dehydration, and gallbladder disease. It should not be combined with other tirzepatide products or GLP-1 receptor agonists.

Zepbound is not specifically approved as a diabetes treatment. Patients seeking tirzepatide primarily for type 2 diabetes should discuss medications approved for that indication, such as Mounjaro.

Schedule an appointment to discuss Zepbound prescription eligibility at DFWPMA Fort Worth.

What Zepbound Prescription Services Are Available at DFWPMA Fort Worth?

DFWPMA Fort Worth provides Zepbound prescription evaluations, weight and metabolic health assessments, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology, internal medicine, and family medicine providers.

Our Zepbound prescription services include:

  • Initial Zepbound Prescription Evaluation: Reviewing BMI, medical history, weight-related conditions, and treatment eligibility.
  • Weight and Metabolic Health Testing: Assessing weight, blood glucose, cholesterol, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Zepbound Prescription and Treatment Planning: Prescribing Zepbound when medically appropriate and establishing weight-management goals.
  • Starting Dose and Titration: Adjusting dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, and other adverse reactions.
  • Weight Loss and Treatment Response Monitoring: Tracking weight changes, medication effectiveness, and treatment progress.
  • Long-Term Weight and Metabolic Care: Managing obesity-related health conditions and supporting sustained weight management.
  • Alternative Weight Loss Medication Evaluation: Considering other approved medications when Zepbound is unsuitable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Zepbound typically starts at 2.5 mg once weekly for four weeks, followed by 5 mg weekly. Further increases occur in 2.5 mg increments after at least four weeks at the current dose, depending on response and tolerance.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention.

The American College of Physicians emphasizes individualized weight-management decisions that consider medication benefits, risks, costs, medical conditions, and long-term health goals.

Source: American College of Physicians – Clinical Guidance on Pharmacologic Weight Management

Not every patient qualifies for Zepbound. A medical evaluation determines whether the medication or an alternative treatment is appropriate. Patients who are pregnant or planning pregnancy should discuss other treatment options.

Looking for Zepbound prescriptions in Fort Worth? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.